Prions: Protein Aggregation and Infectious Diseases

被引:374
作者
Aguzzi, Adriano [1 ]
Calella, Anna Maria [1 ]
机构
[1] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland
关键词
CREUTZFELDT-JAKOB-DISEASE; FOLLICULAR DENDRITIC CELLS; CENTRAL-NERVOUS-SYSTEM; BOVINE SPONGIFORM ENCEPHALOPATHY; CHRONIC WASTING DISEASE; TUMOR-NECROSIS-FACTOR; SCRAPIE AGENT NEUROINVASION; PITUITARY GROWTH-HORMONE; SENSITIVE OPTICAL PROBES; AMYLOID FIBRIL FORMATION;
D O I
10.1152/physrev.00006.2009
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Aguzzi A, Calella AM. Prions: Protein Aggregation and Infectious Diseases. Physiol Rev 89: 1105-1152, 2009; doi:10.1152/physrev.00006.2009.-Transmissible spongiform encephalopathies (TSEs) are inevitably lethal neurodegenerative diseases that affect humans and a large variety of animals. The infectious agent responsible for TSEs is the prion, an abnormally folded and aggregated protein that propagates itself by imposing its conformation onto the cellular prion protein (PrPC) of the host. PrPC is necessary for prion replication and for prion-induced neurodegeneration, yet the proximal causes of neuronal injury and death are still poorly understood. Prion toxicity may arise from the interference with the normal function of PrPC, and therefore, understanding the physiological role of PrPC may help to clarify the mechanism underlying prion diseases. Here we discuss the evolution of the prion concept and how prion-like mechanisms may apply to other protein aggregation diseases. We describe the clinical and the pathological features of the prion diseases in human and animals, the events occurring during neuroinvasion, and the possible scenarios underlying brain damage. Finally, we discuss potential antiprion therapies and current developments in the realm of prion diagnostics.
引用
收藏
页码:1105 / 1152
页数:48
相关论文
共 533 条
[1]   Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function [J].
Adachi, O ;
Kawai, T ;
Takeda, K ;
Matsumoto, M ;
Tsutsui, H ;
Sakagami, M ;
Nakanishi, K ;
Akira, S .
IMMUNITY, 1998, 9 (01) :143-150
[2]   Prion protein amino acid determinants of differential susceptibility and molecular feature of prion strains in mice and voles [J].
Agrimi, Umberto ;
Nonno, Romolo ;
Dell'Omo, Giacomo ;
Di Bari, Michele Angelo ;
Conte, Michela ;
Chiappini, Barbara ;
Esposito, Elena ;
Di Guardo, Giovanni ;
Windl, Otto ;
Vaccari, Gabriele ;
Lipp, Hans-Peter .
PLOS PATHOGENS, 2008, 4 (07)
[3]   Prions, cytokines, and chemokines: A meeting in lymphoid organs [J].
Aguzzi, A ;
Heikenwalder, M .
IMMUNITY, 2005, 22 (02) :145-154
[4]   Antiprion immunotherapy: To suppress or to stimulate? [J].
Aguzzi, A ;
Sigurdson, CJ .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (09) :725-736
[5]   Understanding the diversity of prions [J].
Aguzzi, A .
NATURE CELL BIOLOGY, 2004, 6 (04) :290-292
[6]   Mammalian prion biology: One century of evolving concepts [J].
Aguzzi, A ;
Polymenidou, M .
CELL, 2004, 116 (02) :313-327
[7]   Games played by rogue proteins in prion disorders and Alzheimer's disease [J].
Aguzzi, A ;
Haass, C .
SCIENCE, 2003, 302 (5646) :814-818
[8]   Immune system and peripheral nerves in propagation of prions to CNS [J].
Aguzzi, A ;
Heppner, FL ;
Heikenwalder, M ;
Prinz, M ;
Mertz, K ;
Seeger, H ;
Glatzel, M .
BRITISH MEDICAL BULLETIN, 2003, 66 :141-+
[9]   Spongiform encephalopathies - Between cows and monkeys [J].
Aguzzi, A .
NATURE, 1996, 381 (6585) :734-735
[10]   Neuro-immune connection in spread of prions in the body? [J].
Aguzzi, A .
LANCET, 1997, 349 (9054) :742-743